The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 5,052 companies had the same profile as PHARMACIE RISSELIN has now. Each dot stands for 13 companies, two years later.
95.8%
were still trading
2.4%
stopped another way
1.7%
went bankrupt
Micro
10 to 20 years old
solvency 10 to 30%
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 5,052 companies, not a prediction for PHARMACIE RISSELIN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0847810187
Name after signing inVisible after signing in resigns as director
Gazette deed
Name hiddenVisible after signing in (director) and Hidden nameVisible after signing in (director) appointed
General meeting of 15-11-2023 · Gazette deed
Capital increase of €100,000 to €118,600
The capital rose from €18,600 to €118,600 · General meeting of 14-12-2016 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as PHARMACIE RISSELIN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €784,000 and €868,000, founded between 2006 and 2016.
PHARMACIE RISSELIN has existed since 2012. The gross margin grew from €286,038 in 2013 to €517,831 in 2025 and staff from 2.4 to 4 full-time equivalents.
The company number of PHARMACIE RISSELIN is 0847.810.187. The VAT number is the same number with BE in front: BE 0847.810.187.
Where is PHARMACIE RISSELIN based?
The registered office is at Rue Albert 1er 49, 7600 Péruwelz.Company details
What does PHARMACIE RISSELIN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE RISSELIN?
PHARMACIE RISSELIN is a private limited company (BV).
When was PHARMACIE RISSELIN founded?
PHARMACIE RISSELIN was founded on 02-08-2012.
Is PHARMACIE RISSELIN still active?
Yes, PHARMACIE RISSELIN is an active enterprise in the KBO register.
How many employees does PHARMACIE RISSELIN have?
PHARMACIE RISSELIN had an average of 4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE RISSELIN fall under?
In its 2025 annual accounts, PHARMACIE RISSELIN states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMACIE RISSELIN?
The turnover in financial year 2025 is about €1.8m. This figure is estimated from the gross margin of €517,831 and 42 comparable companies (NACE 477). It probably lies between €1.4m and €2.5m.
Is PHARMACIE RISSELIN profitable?
In financial year 2025, PHARMACIE RISSELIN made a profit of €208,238.
Where can I find the annual accounts of PHARMACIE RISSELIN?
PHARMACIE RISSELIN filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE RISSELIN due?
PHARMACIE RISSELIN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline